Claros Raises Series A

Claros Diagnostics Inc., a Woburn, Mass.-based developer of handheld urological cancer diagnostic testing system for point-of-care use, has raised $7.8 million in Series A funding. Oxford Bioscience Partners led the deal, and was joined by Bioventures Investors, Accelerated Technologies Partners and Commons Capital. www.clarosdx.com